Are you Dr. Pan?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 54 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
1400 Vfw Pkwy
West Roxbury, MA 02132Phone+1 857-203-6189
Summary
- Dr. Chong-Xian Pan, MD is an oncologist in West Roxbury, Massachusetts. He is currently licensed to practice medicine in Massachusetts, California, and Illinois. He is an Associate Professor at UC.
Education & Training
- Indiana University School of MedicineFellowship, Hematology and Medical Oncology, 2002 - 2005
- Ascension Illinois/Saint FrancisResidency, Internal Medicine, 1999 - 2002
- Shanghai Medical UniversityClass of 1989
Certifications & Licensure
- MA State Medical License 2020 - 2025
- CA State Medical License 2005 - 2020
- IL State Medical License 1999 - 2002
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Androgen Ablation Therapy With or Without Chemotherapy in Treating Patients With Metastatic Prostate Cancer Start of enrollment: 2006 Sep 26
- Bicalutamide With or Without Everolimus in Treating Patients With Recurrent or Metastatic Prostate Cancer Start of enrollment: 2008 Dec 01
- Clinical Study of Microdosing Carboplatin in Lung or Bladder Cancer Start of enrollment: 2010 Dec 01
- Join now to see all
Publications & Presentations
PubMed
- 244 citationsCAR race to cancer immunotherapy: from CAR T, CAR NK to CAR macrophage therapy.Kevin Pan, Hizra Farrukh, Veera Chandra Sekhar Reddy Chittepu, Huihong Xu, Chong-Xian Pan
Journal of Experimental & Clinical Cancer Research. 2022-03-31 - 255 citationsCombination strategies to maximize the benefits of cancer immunotherapy.Shaoming Zhu, Tian Zhang, Lei Zheng, Hongtao Liu, Wenru Song
Journal of Hematology & Oncology. 2021-09-27 - 44 citationsIdentification of a bladder cancer-specific ligand using a combinatorial chemistry approachHongyong Zhang, Olulanu H. Aina, Kit S. Lam, Ralph W deVere White, Christopher P. Evans
Urologic Oncology. 2012-09-01
Press Mentions
- Bladder Cancer: Know the SignsJune 15th, 2021